Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

bioAffinity Technologies (BIAF) Leases: 2023-2025

Historic Leases for bioAffinity Technologies (BIAF) over the last 2 years, with Sep 2025 value amounting to $565,030.

  • bioAffinity Technologies' Leases fell 56.34% to $565,030 in Q3 2025 from the same period last year, while for Sep 2025 it was $565,030, marking a year-over-year decrease of 56.34%. This contributed to the annual value of $1.3 million for FY2024, which is negligibly% changed negligibly from last year.
  • Latest data reveals that bioAffinity Technologies reported Leases of $565,030 as of Q3 2025, which was down 0.00% from $565,030 recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Leases ranged from a high of $1.3 million in Q3 2023 and a low of $565,030 during Q2 2025.
  • Its 3-year average for Leases is $1.1 million, with a median of $1.3 million in 2025.
  • Data for bioAffinity Technologies' Leases shows a maximum YoY tumbled of 56.34% (in 2025) over the last 5 years.
  • Over the past 3 years, bioAffinity Technologies' Leases (Quarterly) stood at $1.3 million in 2023, then remained steady at $1.3 million in 2024, then plummeted by 56.34% to $565,030 in 2025.
  • Its Leases stands at $565,030 for Q3 2025, versus $565,030 for Q2 2025 and $1.3 million for Q1 2025.